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Abstract
Background: There is a probable association between consumption of fruit and vegetables and
reduced risk of cancer, particularly cancer of the digestive tract. This anti-cancer activity has been
attributed in part to anti-oxidants present in these foods. Raspberries in particular are a rich source
of the anti-oxidant compounds, such as polyphenols, anthocyanins and ellagitannins.
Methods:  A "colon-available" raspberry extract (CARE) was prepared that contained
phytochemicals surviving a digestion procedure that mimicked the physiochemical conditions of the
upper gastrointestinal tract. The polyphenolic-rich extract was assessed for anti-cancer properties
in a series of in vitro systems that model important stages of colon carcinogenesis, initiation,
promotion and invasion.
Results: The phytochemical composition of CARE was monitored using liquid chromatography
mass spectrometry. The colon-available raspberry extract was reduced in anthocyanins and
ellagitannins compared to the original raspberry juice but enriched in other polyphenols and
polyphenol breakdown products that were more stable to gastrointestinal digestion. Initiation –
CARE caused significant protective effects against DNA damage induced by hydrogen peroxide in
HT29 colon cancer cells measured using single cell microgelelectrophoresis. Promotion – CARE
significantly decreased the population of HT29 cells in the G1 phase of the cell cycle, effectively
reducing the number of cells entering the cell cycle. However, CARE had no effect on epithelial
integrity (barrier function) assessed by recording the trans-epithelial resistance (TER) of CACO-2
cell monolayers. Invasion – CARE caused significant inhibition of HT115 colon cancer cell invasion
using the matrigel invasion assay.
Conclusion: The results indicate that raspberry phytochemicals likely to reach the colon are
capable of inhibiting several important stages in colon carcinogenesis in vitro.
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Background
Epidemiological studies have consistently shown associa-
tion between the consumption of fruit and vegetables and
a reduced risk of human pathologies, such as cardiovascu-
lar disease and cancer [1-3]. Cancers of the digestive tract,
in particular colorectal cancer (CRC), are amongst those
most responsive to dietary modification. Epidemiological
studies have shown that approximately 75 % of all spo-
radic cases of CRC are directly influenced by diet [4], and
that dietary modification is a feasible strategy for reducing
CRC risk [5].
There are many stages involved in the development of
cancer and those involved in CRC development have been
well studied [6,7]. The main events in colon cancer devel-
opment can be classified as initiation, promotion and
metastasis. Under certain conditions, the overproduction
of reactive oxygen species can lead to free radical induced
damage to DNA [8]. Left unrepaired by the endogenous
DNA repair mechanisms [9] this damage could be incor-
porated as a permanent sequence change, potentially ini-
tiating the multi-step pathways involved in carcinogenesis
[2,10]. Normal cell growth and proliferation are regulated
by tumour suppressor genes and proto-oncogenes, which
control cell cycle and apoptosis. However, several tumour
suppressor genes are known to be inactivated with the
parallel activation of key oncogenes via mutation, which
can result in upregulated and uncontrolled proliferation
of cancer cells, allowing colon cancer to progress [7,11].
The protective effect of fruits and vegetables may be due to
the biological activities of dietary fibre, vitamins, minerals
and/or phytochemicals [12,13]. Phytochemicals can be
defined as bioactive non-nutrient components of fruits
and vegetables and are split into groups such as caroten-
oids, polyphenols, alkaloids and other nitrogen-contain-
ing compounds [14]. The chemopreventive nature of
certain phytochemicals may arise because of their antioxi-
dant activity or, more precisely, their ability to inactivate
reactive oxygen species involved in initiation and progres-
sion of colon cancer [3,13]. In addition, sufficient intake
of these phytochemicals in the diet may prevent cancer by
decreasing the damage to DNA via oxidative stress, and
also through enhanced DNA repair [9,10,15].
Berries such as blackberries, strawberries, raspberries and
blueberries provide a rich, diverse and species-specific
source of dietary antioxidants, especially the polyphenols,
[16,12]. A recent study by Halvorsen et al stated that fruits
from the Rosaceae family, including raspberries, were par-
ticularly rich in antioxidants [17]. Phytochemicals from
different soft fruits, including raspberries, have been iden-
tified as effective inhibitors of oxidative DNA damage in
immortalised human colon cells [18]. Other studies have
shown that phytochemicals from berries, berry fractions
and purified anthocyanins have antiproliferative effects
on colon cancer cells in vitro [11,19,20]. There is also evi-
dence that polyphenols present in fruit can prevent metas-
tases and invasion of cancer cells in vitro [21,22].
Several studies have concentrated on the chemopreven-
tive nature of specific polyphenols [23,24]. These studies
involved single compounds used at high concentrations
over an extended time period (up to 72 hr) [11,13,19,25].
Whilst this information may be useful to define the mech-
anisms involved in cancer development in humans [12],
these studies do not allow for the possibility of additive or
synergistic effects [10,15,12]. In addition, the experimen-
tal conditions are far from physiological. Phytochemicals
differ widely in their bioavailability; some phytochemi-
cals are poorly bioavailable [26] and/or are unstable
under the conditions of the gastrointestinal tract (GIT)
[27]. Therefore, studies carried out on pure phytochemi-
cals [28] or berry extracts [11] are unrealistic unless the
bioavailability of the phytochemicals has been well
defined. In the present study, we have used an in vitro
digestion procedure that mimics the physiochemical
changes that occur in the upper GIT, particularly the stom-
ach and small intestine, to produce a representative set of
phytochemicals that could come into contact with the
colonic epithelium in situ. The aim of this study is to
examine the effects of this colon-available raspberry
extract on a series of events that are biologically relevant
to CRC, and which represent the major stages in colorectal
carcinogenesis: initiation, promotion and metastasis.
These in vitro studies use cell lines widely employed as
models of colorectal cancer including HT29 for DNA
damage, genotoxicity and cell cycle events, HT115 for
invasion studies, and CACO-2 cells for barrier function
studies.
Methods
Reagents
Dulbecco's Modified Eagle Medium (DMEM), Minimum
Essential Medium (MEM), and foetal bovine serum (FBS)
were obtained from Gibco Life Technologies Ltd (Paisley,
Scotland, UK). Non-essential amino acids (NEAA), l-
glutamine, penicillin/streptomycin, hydrogen peroxide,
propionate, trypsin, and deoxycholic acid were obtained
from Sigma-Aldrich Company Ltd (Dorset, England, UK).
Raspberry extract
The study used Scottish raspberries (Rubus idaeus L. variety
Glen Ample) purchased at full ripeness from farmers local
to the Scottish Crop Research Institute. Polyphenol-rich
fractions devoid of vitamin C, organic acids and caroten-
oids were obtained using an adaptation of a well-
described method [29] published previously [30].Journal of Carcinogenesis 2007, 6:4 http://www.carcinogenesis.com/content/6/1/4
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Raspberry extract was obtained from ripe berries by
homogenising with solvent (2% (v/v) glacial acetic acid in
acetonitrile), then removing the solvent by rotary evapo-
ration. The remaining raspberry extract was subjected to
an in vitro procedure that simulates the digestive process
as described previously [27]. The procedure was adapted
from the method outlined by Gil-Izquierdo et al [31]. The
method consists of two sequential steps; an initial pepsin/
HCl digestion to simulate gastric conditions followed by
a digestion with bile salts/pancreatin to simulate small
intestine conditions. The final raspberry extract was
diluted in distilled water to a concentration of soluble
phenols similar to that of the original raspberry extract
obtained after rotary evaporation.
Briefly, the original raspberry extract (final volume 20 ml)
was then adjusted to pH 1.7 with 5N HCl then pepsin
(Sigma Chem. Co Ltd) was added at 315 units/ml and
incubated at 37°C in a heated water bath for two hours
with shaking at 100 rpm. 2 ml aliquots of the post-gastric
digestion were removed and frozen. The remainder was
placed in a 250 ml glass beaker and 4.5 ml of 4 mg/ml
pancreatin, 25 mg/ml bile salts mixture added. A segment
of cellulose dialysis tubing (molecular mass cut-off 12
kDa) containing sufficient NaHCO3 to neutralise the sam-
ple's titratable acidity was added and the beaker sealed
with parafilm. After 2 hours incubation at 37°C, the solu-
tion outside the dialysis tubing was taken as the OUT sam-
ple representing material that would reach the colon, and
the solution inside the dialysis tubing was taken as the IN
sample representing the serum available material. 2 ml
samples of the IN and OUT material were taken and fro-
zen. The NaHCO3 diffused out of the dialysis tubing and
the pH of the OUT sample reached neutrality within 30–
45 mins.
The amount of 1 M NaHCO3 required to neutralise an 18
ml aliquot of the post gastric digest plus 4.5 ml bile pan-
creatin/salts was defined as the titratable acidity. The post
gastric, IN and OUT samples were thawed when required,
centrifuged at 13,200 rcf in a microfuge and the superna-
tants assayed for anthocyanin and phenol content.
The total anthocyanin concentration was estimated by a
pH differential method [32]. The absorbance value was
related to anthocyanin content using the molar extinction
coefficient calculated in-house for cyanidin-3-0-glucoside
(CyG). Phenol content was measured using a modified
Folin-Ciocalteau method [33] with a standard curve of
gallic acid. All results have been corrected for the presence
of phenols in the pancreatin/bile salts mixture.
The colon-available raspberry extract (CARE) was acidi-
fied to 0.5 % (v/v) by slow addition of 10% formic acid.
The soluble material was passed through C18 solid phase
extraction columns (1,000 mg capacity, Phenomenex Ltd,
Macclesfield, UK) which had been pre-equilibrated in
ultra pure water (UPW) containing 0.25 % (v/v) formic
acid (FA). After a wash with 2 volumes of FA/UPW, the
bound material was eluted by the addition of 0.25% (v/v)
FA in 25 % (v/v) acetonitrile. This afforded complete sep-
aration of total phenolics from the bile salts present in the
CARE samples. Recovery of cyanidin-3-0-glucoside from
the SPE procedure was around 90%. The fractions were
then dried in a speed-vac (Thermo-Scientific Ltd, High
Wycombe, UK) to suitable phenol concentrations for LC-
MS.
Liquid Chromatography-Mass Spectroscopy (LC-MSn)
Samples (containing 40 µg gallic acid equivalents (GAE)
by Folin assay) were analyzed on a LCQ-DECA system,
comprising Surveyor autosampler, pump and photo
diode array detector (PDAD) and a Thermo-Finnigan
mass spectrometer iontrap. Three discrete channels were
scanned at 280 nm, 365 nm and 520 nm. Samples were
eluted over a gradient of 5% acetonitrile (0.5% formic
acid) to 30% acetonitrile (0.5% formic acid) on a C18 col-
umn (Synergi Hydro C18 with polar end capping, 4.6 mm
× 150 mm, Phenomenex Ltd, Macclesfield, UK) over 60
mins at a rate of 400 µl/min. The LCQ-DECA LC-MS was
fitted with an electrospray ionisation interface and ana-
lyzed the samples in positive and negative ion mode.
There were 2 scan events; full scan analysis followed by
data dependent MS/MS of most intense ions. The data-
dependent MS/MS used collision energies (source volt-
age) of 45% in wideband activation mode. Representative
chromatographs are presented.
Tissue culture
Human colon cancer cells HT29 (adenocarcinoma),
HT115 (carcinoma), CACO-2 (adenocarcinoma), and
human lung tissue MRC5 cells were obtained from the
European Collection of Cell Cultures (ECACC), Salisbury,
UK. HT29 and HT115 cells were cultured as monolayers
in Roux flasks in DMEM culture medium containing 10%
and 15% FBS respectively, 2 mM l-glutamine and 100 U/l
penicillin/streptomycin. HT115 cell culture medium was
also supplemented with 1% NEAA. CACO-2 and MRC5
cells were cultured as monolayers in Roux flasks in MEM
culture medium containing 10% FBS, 2 mM l-glutamine
and 100U/l penicillin/streptomycin and 1% NEAA. Cells
were cultured for 7 days (up to 75% confluence) at 37°C
with 5% CO2 and 95% humidity. The growth medium
was changed every 2 days. Cells were washed for 2 min
with PBS and re-suspended by the addition of trypsin
(0.25% trypsin-EDTA) at 37°C for 5 min. Cells were cen-
trifuged at 1,200 rpm for 3 min, the trypsin decanted and
cells re-suspended in the appropriate medium.Journal of Carcinogenesis 2007, 6:4 http://www.carcinogenesis.com/content/6/1/4
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COMET assay
The effect of CARE on colonocyte DNA damage using the
well-established HT29 cell model [34] was determined.
Flasks of HT29 cells were incubated with CARE at various
concentrations (0, 3.125, 6.25, 12.5, 25, 50 µg/ml) for 24
hr prior to the cells being harvested for subsequent assay.
The genotoxic potential of CARE was assessed by treating
HT29 cells with extracts in the absence of hydrogen perox-
ide. The HT29 cells pre-incubated with CARE were treated
(75 µM H2O2 or PBS) for 5 min on ice, prior to centrifu-
gation at 1,200 rpm for 5 min. Positive (HT29 cells + 75
µM H2O2) and negative (HT29 cells + PBS) controls were
included in all experiments, and these control cells were
not exposed to CARE.
After discarding the supernatant, the cells were reconsti-
tuted in 85 µl of 0.85% low melting point agarose in PBS
and maintained in a water bath at 40°C. This suspension
was mixed with 1% normal agarose gels on frosted slides
and coverslips were added. The slides were subjected to
lysis buffer (2.5 M NaCl, 100 mM Na2EDTA, 10 mM TRIS
HCl) for 1 hr at 4°C and placed in electrophoresis buffer
for 20 min to allow the DNA to unwind before electro-
phoresis at 25 V 300 mA for 20 min. Slides were washed
(3 × 5 min) in neutralisation buffer (0.4 M TRIS HCl, pH
= 7.5) at 4°C. All slides were stained with ethidium bro-
mide (20 µl of 2 µg/ml) prior to scoring. Images were ana-
lysed at 400 × magnification using a Nikon eclipse 600
epi-fluorescence microscope. The % Tail DNA was
recorded using Komet 3.0 image analysis software
(Kinetic Imaging Ltd, Liverpool, UK). 100 cells per slide
were scored. The mean was calculated from 100 cells/gel
(each sample in triplicate) and the experiment repeated
independently 3 times.
Trans-epithelial resistance assay
Cultured CACO-2 cells form atypical brush border mem-
branes and tight junctions through enterocytic differenti-
ation [35] and they provide an appropriate and frequently
used model for the study of permeability, barrier function
and transportation [36,37]. Tight junction integrity
(number and complexity of strands) correlates with the
electrical resistance of the barrier formed. CACO-2 cells
were seeded into 6-well plates with Transwell inserts
(0.1% rat tail collagen coated polyethyleneterapthalate
membranes; BD Bioscience, Bedford, UK) at a seeding
density of 2.5 × 105 cells per well. The growth medium
was changed every other day (apical = 2.5 ml, basolateral
= 1.5 ml) for 21 days. Cells were maintained at 37°C in an
atmosphere of 5% CO2 and 95% humidity. From day 7
the integrity of the monolayer was evaluated by measur-
ing the trans-epithelial resistance (TER) (expressed as
Ωcm2) using an EVOM epithelial voltohmmeter (World
Precision Instruments Ltd, Aston, UK). The inserts were
ready for experimentation when the TER values had stabi-
lised, usually after 20 days of growth. The TER of the
CACO-2 cell monolayers was measured at 0, 24 and 48
hours after addition of CARE (0, 3.125, 6.25, 12.5, 25, 50
µg/ml) to the apical compartment. Positive (10 mM Pro-
pionate) and negative (250 µM deoxycholic acid) controls
were included in all experiments. Baseline resistance was
recorded in the range of 929–1040 Ωcm2 at the start of
each experiment. The treatments were carried out in trip-
licate and each experiment repeated 3 times independ-
ently.
Matrigel invasion assay
This assay has been modified from a method described
previously [38]. Invasion rates of HT115 cells are
enhanced in the presence of MRC5 foetal lung cells, as the
latter secrete hepatocyte growth factor, a strong chemo-
attractant, which has been shown to increase cell scatter-
ing and motility in HT115 cells [39,40]. Briefly, 6-well
Biocoat Matrigel invasion chamber inserts (BD Bio-
science) were rehydrated with 2 ml serum-free culture
medium (37°C) for 2 hr. In a separate plate, MRC5 cells
in suspension were seeded into the basolateral chambers
(4 × 105 cells/well) and incubated at 37°C for 2 hr. The
media and any unattached cells in each well was carefully
removed and replaced with 2 ml of DMEM containing
10% FBS. The rehydrated inserts were then transferred to
the plates containing the MRC5 cells where the media
from the inserts was removed and replaced with 2 ml
HT115 cell suspension (2 × 105  cells in serum-free
DMEM) in the presence or absence of CARE (0, 3.125,
6.25, 12.5, 25, 50 µg/ml). Inserts containing cells plus
media were used as a control. Plates were incubated at
37°C for 24 hr. After incubation the media from both
chambers was removed and the cells in both chambers
fixed with 70% ethanol for 30 min prior to staining with
haematoxylin. Using a cotton bud, the non-invasive cells
were removed from half of the membrane of the upper
chamber by "scrubbing". This was repeated for the inva-
sive cells on the other side of the insert. The number of
invasive and non-invasive cells was then counted in 5 ran-
dom fields, and the percentage invasion calculated. The
total number of cells was also estimated by adding the
mean number of invasive and non-invasive cells counted
on the inserts. Each treatment was carried out in duplicate
and the experiment repeated independently 3 times.
Cell viability and cell cycle analysis
HT29 cells were harvested and seeded at 3 × 105 cells per
flask into 25 cm3 flasks 48 hr prior to treatment, and
maintained at 37°C with 5% CO 2 and 95% humidity.
Media was replaced with media containing CARE (0,
3.125, 6.25, 12.5, 25, 50 µg/ml) and the cells incubated
for 24 hr. Cells were then washed with PBS and re-sus-
pended by the addition of 1 ml trypsin EDTA and incu-
bated at 37°C for 5 min. The trypsin was inactivated byJournal of Carcinogenesis 2007, 6:4 http://www.carcinogenesis.com/content/6/1/4
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the addition of 2 ml of serum-containing medium. A cell
viability count was carried out using a haemocytometer
and trypan blue dye (Sigma). The cells centrifuged at
1,200 rpm for 3 min in polypropylene tubes (Becton
Dickinson). The supernatant was decanted and the pellet
re-suspended in a mixture of ice cold PBS and 70% etha-
nol/30% PBS (200 µl and 2 ml respectively). Cells were
incubated for 30 min on ice before centrifugation at 1,200
rpm for 3 min, and the supernatant carefully discarded.
Cells were then re-suspended in 800 µl of ice cold PBS,
100 µl of RNase A (1 mg/ml) (Sigma Chemicals), and 100
µl of propidium iodide (400 µg/ml) (Sigma Chemicals)
before being incubated at 37°C for 30 min prior to anal-
ysis. Samples were processed on a FACSCalibur flow
cytometer (Becton Dickinson) equipped with laser (exci-
tation wave length = 488 nm). The fluorescence intensity
of propidium iodide was collected at 585 nm (designated
FL2 on FACSCalibur), using CellQuest Software (Becton
Dickinson). In total, 10,000 events were captured. The
intensities were analysed subsequently for DNA content
using WinMDI Version 2.8 (Trotter Institute, JScripts, CA).
Each experiment was completed in duplicate and the data
set is the mean of 3 independent experiments.
Statistical analysis
The mean of each data set was used for statistical analysis
for each experiment. Analysis of variance was applied to
test for significant differences between means by ANOVA
and Dunnett T-test where significance was accepted at p <
0.05. These were carried out in SPSS (version 11.5) for
Windows.
Results
Liquid Chromatography-Mass Spectroscopy (LC-MSn)
The original raspberry extract had a similar polyphenol
composition to previous reports [41,42] with an anthocy-
anin content of 15.9 µg/ml compared to 100 µg/ml for
total phenols. The HPLC profile of the raspberry extract
was similar to previous reports [43,44,27,30,45] and was
mainly composed of anthocyanins (peaks 1–8; Table 1)
and ellagitannins (peaks 9–11; Table 1) with a number of
other minor components (Figure 1a). The anthocyanins
were detected by their absorption at 520 nm and their
structures confirmed by mass spectrometry (Table 1). The
most abundant anthocyanin was cyanidin-3-O-sophoro-
side (peak 1), peak 2 was composed of cyanidin-3-O-(2G)-
glucosylrutinoside and peaks 3–8 were not completely
separated but were composed of cyanidin-3-O-glucoside,
pelargonidin-3-O-sophoroside, cyanidin-3-O-rutinoside,
pelargonidin-3-O-(2G)-glucosylrutinoside. Smaller
amounts of pelargonidin-3-O-glucoside and pelargoni-
din-3-O-rutinoside eluted later and could be confirmed
by searching the MS data at their relevant masses.
Peaks 9–11 absorbed well in the UV and gave maxima
around 285 nm. Peak 11 yielded one predominant mass
ion at m/z 1869 in negative mode (Table 1) with smaller
peaks at 1567, 1235, 933, and 633, which may arise from
in-source fragmentation of the m/z 1869 ion. Indeed, the
m/z 1869 ion gave MS2 ions at m/z 1567, 1235, 1103, 933,
897 and 633. The mass ion and the fragment ions were
essentially identical to the pattern obtained for the ellagi-
tannin, Sanguiin H6 [46], which has previously been
identified in near-identical raspberry extracts [27,30,45].
Peak 9 yielded a dominant ion at m/z 1567 in negative
mode (Table 1) which has been assigned to Sanguiin H10
[46], which has a similar structure to Sanguiin H6 but
lacks one hexahdroxydiphenoyl (HHDP) unit. Peak 10
gave an MS spectrum similar to that of peak 11 except it
also contained an appreciable signal at m/z 1401 (Table
1), which has been assigned to Lambertianin C [46].
Therefore, Peak 11 was composed of a mixture of Lamber-
Table 1: Characterisation and identification of CARE by MS
Peak No. TR m/z+ MS2 Putative Identity % Recovery*
13 5 . 5 2 6 1 1 . 1287.2 Cyanidin-3-O-sophoroside 33.8 ± 1.6
23 6 . 3 7 7 5 7 . 3 287.2, 611.1 Cyanidin-3-O-glucosylrutinioside 48.9 ± 2.6
33 8 . 3 4 4 4 9 . 1287.2 Cyanidin-3-O-glucoside 15.5 ± 3.3
43 8 . 8 6 5 9 5 . 1 271.2, 595.1 Pelargonidin-3-O-sophoroside 32.7 ± 3.1
53 9 . 5 9 5 9 5 . 1 287.2, 449.1 Cyanidin-3-O-rutinoside 27.1 ± 3.0
63 8 . 8 7 7 4 1 . 1 271.1, 595.1 Pelargonidin-3-O-glucosylrutinoside 50.0 ± 2.6
74 2 . 4 3 4 3 3 . 1271.1 Pelargonidin-3-O-glucoside 33.0 ± 1.9
84 3 . 3 8 5 7 9 . 1 271.1, 433.0 Pelargonidin-3-O-rutinoside 52.1 ± 3.2
m/s-
9 48.01 1567.1 multiple Sanguiin H6 613.6 ± 14.5
10 49.03 1401.2 multiple Lambertinian C/Sanguiin H10 16.3 ± 2.0
11 50.54 1869.0 multiple Sanguiin H10 27.6 ± 2.2
12 56.25 N/A N/A Hydroxycinnamic acid derivative 61.7 ± 4.3**
* The % recovery based on the peak area of the mass spectrometer response for each m/z. The value is the average of triplicate samples ± standard 
errors.
** The recovery of peak 12 was based on PDA peak size.Journal of Carcinogenesis 2007, 6:4 http://www.carcinogenesis.com/content/6/1/4
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tianin C and Sanguiin H6 similar to that described in pre-
vious work [27,30].
The CARE contained the same major components as the
original raspberry extract (Figure 1b; Table 1) but with
generally depleted levels (e.g. compare the full scale
deflectance (FSD) of Figure 1a and 1b). Peak 13 increased
in apparent abundance but largely because it was uncov-
ered as the levels of the anthocyanins in peaks 3–8
dropped. This compound gave a PDAD spectrum with a
maximum around 325 nm and a shoulder around 280
nm, which suggests a hydroxycinnamic acid derivative
[47] but gives no clear M/Z or MS2 signals in positive or
negative mode. A number of other peaks were either
reduced (Figure 1c) by in vitro digestion or were uncov-
ered or generated (Figure 1d) by this procedure. In vitro
digestion reduced the total phenolic content and the total
anthocyanin content of the CARE to 72.3 % and 83.8 %
respectively compared to the original extract. These recov-
eries appear to be considerably higher than the recovery of
individual polyphenol components (which ranged from
13 - >60 %). However, certain components (e.g. peaks 9)
increased in abundance and other degradation products
of the main components may also contribute to the total
phenol content (by Folins) but may be unidentified by
LC-MS.
COMET assay
There was no significant genotoxic activity observed at any
of the concentrations of CARE (Figure 2) used for pre-
incubation (24 hr) as DNA damage was similar to that
seen in untreated controls (5.75 ± 0.48 % Tail DNA,). A
significant anti-genotoxic effect (p < 0.01) was observed
for HT29 cells challenged with hydrogen peroxide (75 µM
for 5 min) when pre-treated with CARE in a dose-depend-
ant manner (Figure 2) at all concentrations tested. At the
highest concentration of CARE, 50 µg/ml GAE, there was
maximum reduction in DNA damage of approximately
50% (23.87 ± 1.54 %) verses the positive control (44.22 ±
0.62 % Tail DNA). At the lowest concentration of CARE
MS trace of berry extract and CARE Figure 1
MS trace of berry extract and CARE. Comparison of undigested raspberry extract (a) and CARE (b) samples by LC-MS/MS, 
peaks 1 – 12 have been characterised (Table 1). Expanded area of LC trace of whole raspberry extract (c) and CARE (d). 
Arrows in c denote peaks that are reduced by in vitro digestion, arrows in d denote peaks that increase in abundance or are 
only present in the digested sample.
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(3.125 µg/ml GAE) there was a significant decrease in %
tail DNA of approximately 15% (38.5 ± 0.55 % tail DNA)
verses the positive control.
Trans-epithelial resistance assay
The assessment of barrier function was made by recording
changes in transepithelial resistance over a 48 hour time
period after the addition of CARE, with measurements
taken at T0, T24 and T48. The addition of CARE over a range
of concentrations (0 – 50 µg/ml GAE) had no significant
effect on barrier function of the CACO-2 monolayer (data
not shown).
Cell viability and cell cycle analysis
The dose range of CARE tested had no significant effect on
cytotoxicity, as seen in the cell viability data (Figure 3).
The effect of CARE treatment on HT29 cell proliferation
was also evaluated by measuring cell cycle distribution.
The incubation of HT29 cells for 24 hr with 50 µg/ml GAE
CARE caused an approximate 10% decrease in the propor-
tion of cells in the G0/G1 phase of cell cycle, relative to
control cells (p  < 0.05). There were corresponding
increases in cells in the S and G2/M phases but these
changes were not significant. At all other concentrations
tested no significant changes were observed and the cell
cycle profile closely resembled that of the control cells.
Matrigel invasion assay
The effect of different concentrations of CARE on Matrigel
invasion by HT115 cells is shown in Figure 5. At the low-
est concentration used (3.125 µg/ml GAE), the addition
of CARE had no significant effect on invasion rates com-
pared to the control (0 µg/ml GAE, 11.25 ± 1.88 % inva-
sion). All other concentrations of CARE (6.25, 12.5, 25 &
50  µg/ml GAE) significantly inhibited the invasion of
HT115 cells (7.16 ± 2.11, 3.95 ± 1.34, 2.04 ± 0.87 and
0.82 ± 0.46 % invasion respectively). A dose-dependent
decrease in invasion was observed with increasing CARE
concentration (r2 = 0.99). At the lowest significant con-
centration of CARE (6.25 µg/ml GAE), a decrease in inva-
sion of approximately 40% was observed, whilst at the
highest concentration (50 µg/ml GAE) the decrease in
invasion was approximately 90%.
Discussion
The use of crude homogenates of fruit and vegetables in in
vitro studies in colon cells may overestimate the biological
activity since no account is taken of digestion and absorp-
tion on the phytochemical composition. The simulated
digestion used here is not a true representation of human
digestion. For example, the length of digestion is arbitrar-
ily chosen from average transit figures and it cannot repli-
cate the effects of brush border enzyme systems [48]. It
also cannot replicate the effect of microflora in the stom-
ach and small intestine [49]. However it mimics key phys-
iochemical changes of the digestive process to provide an
extract similar in composition to that found to be colon-
available in vivo [27].
In vitro digestion of the raspberry extract produced the
colon-available raspberry extract (CARE) which retained a
considerable portion of the original anthocyanin content
Genotoxic and anti-genotoxic effects of CARE (24 hr incubation) at different concentrations on DNA damage in HT29 cells, n  = 3, mean ± SD, *p < 0.001 Figure 2
Genotoxic and anti-genotoxic effects of CARE (24 hr incubation) at different concentrations on DNA damage in HT29 cells, n 
= 3, mean ± SD, *p < 0.001. Hydrogen peroxide challenge 75 µM.
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(~50%) and the total phenol content (~70%). These fig-
ures are in line with previous studies on the stability of
raspberry anthocyanins [27] and are similar to other in
vitro digestion studies on chokeberry [50] and pomegran-
ate [51].
However, the composition of the individual polyphenolic
components in raspberry is dynamic. For example, certain
anthocyanins are less stable than others. The general pat-
tern is similar to previous reports [27] with cyanidin-3-O-
glucoside being the least stable anthocyanin. The low
recovery may be due to sacrificial oxidation in the rasp-
berry mixture as cyanidin-3-O-glucoside has a higher anti-
oxidant capacity than other anthocyanins [52] and may
be preferentially oxidised.
That ellagitannins are also unstable to the conditions of
gastrointestinal digestion has been well documented
[53,54]. Nevertheless, ~20% of the original content of
lambertianin C and Sanguiin H10 survived the in vitro
digestion and the 6-fold increase in recovery of Sanguiin
H6 would also contribute to a substantial dose of ellagi-
tannins reaching the colon.
The survival of polyphenols into the colon is well docu-
mented. Anthocyanins have been detected in faecal con-
tents [55] and throughout the gastrointestinal tract in pigs
[56]. A large portion of ingested anthocyanins and other
polyphenols pass intact into the colon fraction [57-60]
and may be degraded by fermentation into smaller phe-
nolic compounds by gut microflora and re-absorbed to
contribute to the serum antioxidant capacity.
The increased recovery of Sanguiin H6 is almost certainly
due to the breakdown of Sanguiin H10 through the loss
of a HHDP unit [61], which spontaneously re-arranges to
ellagic acid (EA). EA has been shown to be an effective
anti-cancer agent [62]. The pomegranate ellagitannin,
punicalagin degraded to produce EA in the mildly alkaline
media of cultured CACO-2 cells [63] and raspberry-
derived Sanguiin H10 degrades to EA in similar media of
HeLa cervical cancer cells [45]. However, free EA was not
detected after gastrointestinal digestion. Initial experi-
ments have suggested that EA may have been bound to
proteins in the pancreatin/bile salts mixture and escaped
recovery by solid phase extraction (results not shown).
However, EA bound in this manner may be released in
vivo as the proteins are degraded or as the pH drops in the
fermentative caecum [58]. Indeed, urinary excretion of
urolithin-type degradation products of ellagic acid was
estimated at 14 % of ellagitannin intake from raspberries
[60], which confirms that ellagitannins (and therefore
Cytotoxic effect of CARE on HT29 cells (n = 3) Figure 3
Cytotoxic effect of CARE on HT29 cells (n = 3). No significant cytotoxic effect was observed at any of the concentrations used 
(0, 3.125, 6.25, 12.5, 25, 50 µg/ml).
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ellagic acid) are retained in the gastrointestinal tract and
biotransformed by the colonic microflora.
Cells in the gastrointestinal tract, particularly the colon,
are susceptible to develop mutations due to dietary carcin-
ogens present in the gut, which are in direct contact with
cells of the colon (and may access the blood stream and
cause cell mutations) [64]. These carcinogens trigger
events such as free radical formation and production of
reactive oxygen species, which can cause DNA damage,
and can initiate the cancer process. Conversely, the gut
contents may contain food-derived anti-cancer agents
[65]. A dose response effect was observed for anti-genoto-
xicity with increasing CARE concentration in HT29
human colon cells challenged with H2O2. The reduction
(approximately 50% at the highest concentration used) in
H2O2-induced DNA damage indicates increased cellular
capabilities to protect against damage. Cyanidin-3-gluco-
side, a common berry anthocyanin, pre-incubated for 4
hours at 50 µM with human colon epithelial cells resulted
in almost 40% reduction in DNA damage caused by a
H2O2insult at 200 µM [18]. This concentration is equiva-
lent to 22.5 µg/ml, which is in the same effective range as
the CARE samples used in this study. Preincubation with
the aglycone cyanidin (100 µM for 30 min) caused an
approximate 10% decrease in H2O2-induced DNA dam-
age in HT29 cells when subjected to oxidative insult (75
µM H2O2) [20]. Therefore, CARE has a similar protective
effect against DNA damage as other phytochemicals at
similar concentrations. However, whilst the use of iso-
lated and purified phytochemicals is relevant to deter-
mine specific effects, we maintain that use of a whole
extract, subjected to in vitro digestion, is more physiologi-
cally-relevant to the situation after ingestion of berries and
allows the detection of possible synergistic effects of phy-
tochemicals.
Cell proliferation is important in the development of
colon cancer from the initiation stage. As the cells con-
tinue to divide, they acquire more defects in key genes
allowing the cell to continue growing [7]. Cell prolifera-
tion in normal cells is regulated at the cell cycle check-
points G1/S and G2/M, at which time correct DNA
synthesis and chromosomal segregation is maintained.
However in cancerous cells, particularly in colon cancer,
these regulatory mechanisms are defective, and cells
undergo growth and division unchecked. Therefore, we
investigated the effect of CARE on proliferation of colon
cancer cells by measuring barrier function and cell cycle
profile. There was no significant increase or decrease in
barrier function of CACO-2 cells at any concentrations of
CARE used, suggesting that the addition of digested rasp-
berry extract had no effect on epithelial integrity. How-
ever, a significant decrease in HT29 cells in the G0/G1
phase of the cell cycle was observed at the highest concen-
tration used (50 µg/ml GAE), causing a slight, but not sta-
tistically significant increase in cells accumulating in the S
and G2/M phases. This suggests that although cells treated
with CARE have circumvented the normal cell cycle con-
trol at G1/S, they are unable to complete the cell cycle,
indicating that CARE could restrict cell proliferation in
vitro. Anthocyanin-rich extracts from chokeberries inhib-
ited growth and cell cycle progression of HT29 cells [66].
Approximately 60% growth inhibition was observed after
a 24 hr pre-incubation with 50 µg/ml extract, and the cell
cycle was halted at the G1/S and G2/M checkpoints [66].
Therefore, CARE reduced cell cycle progression and pre-
vented cell proliferation at similar concentrations to other
berry extracts. There is evidence that there is considerable
potential for antiproliferative synergy between polyphe-
nolic components. Seeram et al. observed approximately
30% inhibition in proliferation in a human metastatic
colon cancer cell line (SW620) when pre-treated with
total cranberry extract (200 µg/ml for 48 hr) [19]. At sim-
ilar concentrations, isolated cranberry anthocyanins
caused an approximate 10% decrease in cell proliferation,
indicating an additive or synergistic antiproliferative effect
resulting from the combination of phytochemicals
present in the extract. Similar synergistic effects on apop-
totic cell death in human colon HT29 and HT116 cells
were noted for whole pomegranate extracts (100 µg/ml
for 24 hours) over isolated pomegranate ellagitannins
[67].
The final important stage in cancer development is the
spread of cancer to other tissues. CARE (at 6.25 – 50 µg/
ml GAE) significantly reduced the invasiveness of HT115
colon cancer cells in vitro. At the highest concentration of
CARE, there was almost a 95% reduction in cell invasive-
ness and this reduction was directly related to CARE dose.
In other studies, Kim et al. demonstrated a 75% inhibition
of invasion in MCF-7 breast cancer cells using pomegran-
ate seed oil at 10 µg/ml [68]. Pomegranate seed oil con-
tains various phytochemicals including β-sitosterol and
anthocyanins, which previous studies have shown are
important in regulating various stages of carcinogenesis
[13,18]. However, little is known about the stability of
these components to gastrointestinal digestion. Epigallo-
catechin-3-gallate (EGCG), which is isolated from green
tea, can inhibit invasion of various carcinomas, including
pancreatic carcinoma cells [69], and human biliary tract
carcinoma cells [70] at concentrations of 100 µg/ml. The
invasive capacity of pancreatic cell lines, PANC-1, MIA
PaCa-2 and BxPC-3, was reduced after pre-treatment with
100 µg/ml EGCG for 2 hours [69]. It is notable that CARE
was effective at a similar concentration and timescale,
even though direct comparison between different cell
lines and different extracts is difficult.Journal of Carcinogenesis 2007, 6:4 http://www.carcinogenesis.com/content/6/1/4
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Whilst the bioavailability of different phytochemicals
remains relatively unexplored, many polyphenols have
poor in vivo serum bioavailability [71,72,26,65]. In partic-
ular, the major polyphenol components of raspberry,
anthocyanins and ellagitannins, are generally considered
to have poor serum bioavailability [67,52,73]. However,
cancers of the alimentary canal are unique in that the
abnormal cells can be in direct contact with food-derived
potential anti-cancer agents present in the intestinal
lumen. Also, unabsorbed phytochemicals may have direct
chemopreventive activity on cells predisposed to develop
mutations in the gastrointestinal tract, without accessing
the blood circulation system, through prevention of lipid/
protein oxidation [65,74]. New polyphenol compounds
were formed during the digestive process, which were not
present in the original raspberry extract. Further work is
required to discern the nature of these components
although it is probable that they are breakdown products
formed from the major components. Although present in
small amounts, these components may have significant
effects (alone or in concert) that would not be observed
when using a purified compound or a non-digested
extract.
Conclusion
A considerable weight of evidence has been gathered that
suggests that consumption of fruit and vegetables is
advantageous to our health and may help to prevent
chronic diseases such as cancer [1-3]. The data obtained in
our in vitro study supports this view and provides insight
into the possible stages at which raspberry phytochemi-
cals may act to halt the progression of cancer. We have
demonstrated that CARE can inhibit in vitro models of key
stages in colorectal cancer development, namely initia-
tion, promotion and invasiveness. Further insights into
the anti-cancer effects of CARE may require the use of a
suitable animal model.
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